Viewing Study NCT00976261


Ignite Creation Date: 2025-12-24 @ 12:18 PM
Ignite Modification Date: 2026-02-25 @ 7:28 PM
Study NCT ID: NCT00976261
Status: COMPLETED
Last Update Posted: 2017-06-08
First Post: 2009-09-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 2 diabetes View
None single dose View
None 3-O-methylglucose View
None healthy volunteer View
None repeat dose View